ATE103187T1 - Haemostastische collagenpastenmaterialzusammensetzung. - Google Patents

Haemostastische collagenpastenmaterialzusammensetzung.

Info

Publication number
ATE103187T1
ATE103187T1 AT89312777T AT89312777T ATE103187T1 AT E103187 T1 ATE103187 T1 AT E103187T1 AT 89312777 T AT89312777 T AT 89312777T AT 89312777 T AT89312777 T AT 89312777T AT E103187 T1 ATE103187 T1 AT E103187T1
Authority
AT
Austria
Prior art keywords
hemostatic
haemostastic
material composition
paste material
collagen
Prior art date
Application number
AT89312777T
Other languages
English (en)
Inventor
Lowell Saferstein
Stephen Jeffrey Wolf
Original Assignee
Johnson & Johnson Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical filed Critical Johnson & Johnson Medical
Application granted granted Critical
Publication of ATE103187T1 publication Critical patent/ATE103187T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89312777T 1988-12-08 1989-12-07 Haemostastische collagenpastenmaterialzusammensetzung. ATE103187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/282,224 US4891359A (en) 1988-12-08 1988-12-08 Hemostatic collagen paste composition
EP89312777A EP0372966B1 (de) 1988-12-08 1989-12-07 Hämostastische Collagenpastenmaterialzusammensetzung

Publications (1)

Publication Number Publication Date
ATE103187T1 true ATE103187T1 (de) 1994-04-15

Family

ID=23080569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89312777T ATE103187T1 (de) 1988-12-08 1989-12-07 Haemostastische collagenpastenmaterialzusammensetzung.

Country Status (10)

Country Link
US (1) US4891359A (de)
EP (1) EP0372966B1 (de)
JP (1) JP3195335B2 (de)
AT (1) ATE103187T1 (de)
AU (1) AU623456B2 (de)
CA (1) CA2004739C (de)
DE (1) DE68914110T2 (de)
ES (1) ES2062041T3 (de)
IE (1) IE62927B1 (de)
ZA (1) ZA899372B (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466383A1 (de) * 1990-07-09 1992-01-15 BAUSCH & LOMB INCORPORATED Medizinischer Kollagenleim und seine Verwendungen
US6350274B1 (en) 1992-05-11 2002-02-26 Regen Biologics, Inc. Soft tissue closure systems
US5326350A (en) * 1992-05-11 1994-07-05 Li Shu Tung Soft tissue closure systems
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
ES2227542T3 (es) * 1993-11-03 2005-04-01 Clarion Pharmaceuticals, Inc. Parche hemostatico.
US6033401A (en) 1997-03-12 2000-03-07 Advanced Closure Systems, Inc. Vascular sealing device with microwave antenna
US6302898B1 (en) 1994-06-24 2001-10-16 Advanced Closure Systems, Inc. Devices for sealing punctures in body vessels
US5562946A (en) * 1994-11-02 1996-10-08 Tissue Engineering, Inc. Apparatus and method for spinning and processing collagen fiber
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
AU5638096A (en) * 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
US5911942A (en) * 1995-11-02 1999-06-15 Tissue Engineering, Inc. Method for spinning and processing collagen fiber
CA2251475C (en) * 1996-04-04 2006-09-05 Immuno Aktiengesellschaft Hemostatic sponge based on collagen
US6492508B1 (en) * 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
US6927287B1 (en) * 1996-06-03 2005-08-09 United States Surgical Corporation Nucleic acid encoding extracellular matrix protein or fragment thereof
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
CZ54899A3 (cs) * 1996-08-23 1999-08-11 Cook Biotech, Incorporated Štěpová protéza, materiály s ní spojené a způsoby její výroby
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6743248B2 (en) 1996-12-18 2004-06-01 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
EP1019106A1 (de) * 1997-01-16 2000-07-19 Cohesion Corporation Biomaterial basiert auf lyophilisiertem kollagen sowie verfahren zu dessen herstellung und dessen verwendung
US20040176801A1 (en) * 1997-03-12 2004-09-09 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
US6733515B1 (en) 1997-03-12 2004-05-11 Neomend, Inc. Universal introducer
US20030191496A1 (en) * 1997-03-12 2003-10-09 Neomend, Inc. Vascular sealing device with microwave antenna
US6475182B1 (en) 1997-03-12 2002-11-05 Olexander Hnojewyj Fluidic media introduction apparatus
EP0993311B1 (de) * 1997-06-18 2012-11-14 Angiotech Pharmaceuticals (US), Inc. Thrombin und mikrofibrillares collagen enthaltene zusammensetzung sowie herstellungsmethoden und dessen gebrauch
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
EP1051116B8 (de) * 1998-12-01 2009-06-10 Washington University Vorrichtung zur intravaskulären embolisierung
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6361551B1 (en) 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US7094428B2 (en) * 2000-06-16 2006-08-22 The University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
CA2433850A1 (en) * 2001-01-04 2002-09-12 Osteotech, Inc. Method for sterilizing bioactive materials
US20030211793A1 (en) * 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
ATE448808T1 (de) * 2001-12-21 2009-12-15 Ferrosan As Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung
MXPA05006193A (es) * 2002-12-11 2005-12-05 Ferrosan As Materiales basados en gelatina como hisopos.
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US8440225B2 (en) * 2003-08-07 2013-05-14 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20060019868A1 (en) * 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
CN1921896B (zh) * 2004-01-30 2010-11-24 弗罗桑公司 止血喷雾剂和组合物
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)
US8119160B2 (en) 2004-06-29 2012-02-21 Ethicon, Inc. Hemostatic compositions and devices
RU2369408C2 (ru) * 2004-07-09 2009-10-10 Ферросан А/С Гемостатическая композиция, включающая гиалуроновую кислоту
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
EP1833517B1 (de) * 2004-12-14 2008-09-24 Fidia Advanced Biopolymers S.R.L. Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten
MX2008014847A (es) * 2006-05-31 2009-04-30 Baxter Int Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
TWI436793B (zh) * 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
US7718616B2 (en) * 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
TWI461227B (zh) 2007-10-30 2014-11-21 Baxter Int 再生生物功能性膠原生物基質用來治療內臟或體壁缺陷的用途
EP2259803B2 (de) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Vorrichtung zur förderung von hämostase und/oder wundheilung
US8840913B2 (en) * 2008-03-27 2014-09-23 Warsaw Orthopedic, Inc. Malleable multi-component implants and materials therefor
US9629798B2 (en) * 2008-04-03 2017-04-25 Mallinckrodt Pharma Ip Trading D.A.C. Hemostatic microspheres
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
ES2532428T3 (es) 2009-06-16 2015-03-26 Baxter International Inc Esponja hemostática
GB2487773B (en) * 2011-02-04 2014-09-17 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
US9629913B2 (en) * 2009-07-21 2017-04-25 Aidance Skincare And Topical Solutions, Llc Silver oxide formulations
US8652509B2 (en) * 2009-11-02 2014-02-18 Moshe Rogosnitzky Method of wound hemostasis using liquid gallium nitrate
MX2012007056A (es) 2009-12-16 2012-09-28 Baxter Healthcare Sa Esponja hemostatica.
RU2012143739A (ru) 2010-03-15 2014-04-20 Ферросан Медикал Дивайсиз А/С Способ ускорения остановки кровотечения и/или заживления ран
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
JP6289096B2 (ja) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血組成物を作製するためのプロセス
EP2575775B1 (de) 2010-06-01 2018-04-04 Baxter International Inc. Verfahren zur herstellung von trockenen und stabilen hämostatischen zusammensetzungen
WO2011151386A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
WO2012068135A1 (en) 2010-11-15 2012-05-24 Zimmer Orthobiologics, Inc. Bone void fillers
US10022410B2 (en) * 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
WO2012122044A2 (en) 2011-03-04 2012-09-13 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
EP4137165A1 (de) 2011-10-11 2023-02-22 Baxter International Inc. Hämostatische zusammensetzungen
AU2012318258B2 (en) 2011-10-11 2015-07-09 Baxter Healthcare S.A. Hemostatic compositions
WO2013060770A1 (en) 2011-10-27 2013-05-02 Baxter International Inc. Hemostatic compositions
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
RU2636240C2 (ru) * 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
CN105358071B (zh) 2013-06-21 2018-07-31 弗罗桑医疗设备公司 真空膨胀的干组合物和用于保留该干组合物的注射器
WO2015086028A1 (en) 2013-12-11 2015-06-18 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
KR101649450B1 (ko) * 2015-08-19 2016-08-18 이상철 피부 상처 치료조성물
CN110087697A (zh) * 2016-08-12 2019-08-02 比奥马普公司 止血可流动物
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
US11007299B2 (en) 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
BR112020016593B1 (pt) 2018-02-15 2023-11-14 Biom'up France SAS Produto hemostático impresso, uso de fluido hemostático e método de fabricação de produtos hemostáticos
EP3790600B1 (de) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Verfahren zur herstellung einer hämostatischen zusammensetzung
CN110652648B (zh) * 2018-08-01 2021-05-28 浙江探针生物科技有限公司 输送药剂的器件及其装置和组件
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US12285540B2 (en) 2020-07-21 2025-04-29 Ethicon, Inc. Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents
CA3227151A1 (en) 2021-07-21 2023-01-26 Organogenesis Inc. Porcine collagen compositions and methods of use thereof
US20230047711A1 (en) * 2021-08-13 2023-02-16 Sasan Najibi Flowable collagen colloid and method of forming
US20230079760A1 (en) * 2021-09-13 2023-03-16 Medtronic Inc. Surgical system and methods of use
CN114288463B (zh) * 2021-12-13 2022-07-05 鹏拓生物科技(杭州)有限公司 一种流体胶原蛋白止血材料的研制方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579367A (en) * 1950-11-24 1951-12-18 Hynson Westcott & Dunning Inc Bandage
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
JPS5837330B2 (ja) * 1975-05-01 1983-08-16 カブシキガイシヤ ニツピ シケツヨウコラ−ゲンフンマツノセイゾウホウホウ
GB1584080A (en) * 1977-12-05 1981-02-04 Ethicon Inc Absorbable hemostatic composition
US4215200A (en) * 1978-10-02 1980-07-29 Cornell Research Foundation, Inc. Chemically and enzymatically modified collagen hemostatic agent
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen

Also Published As

Publication number Publication date
IE893928L (en) 1990-06-08
EP0372966A2 (de) 1990-06-13
AU4603789A (en) 1990-06-14
DE68914110T2 (de) 1994-07-07
ZA899372B (en) 1991-08-28
CA2004739C (en) 2000-03-28
CA2004739A1 (en) 1990-06-08
EP0372966B1 (de) 1994-03-23
US4891359A (en) 1990-01-02
IE62927B1 (en) 1995-03-08
AU623456B2 (en) 1992-05-14
JPH02218616A (ja) 1990-08-31
JP3195335B2 (ja) 2001-08-06
EP0372966A3 (en) 1990-12-27
DE68914110D1 (de) 1994-04-28
ES2062041T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DE68914110D1 (de) Hämostastische Collagenpastenmaterialzusammensetzung.
ATE24838T1 (de) Lyophilisierte zusammensetzungen, ihre herstellung und verwendung.
ATE57616T1 (de) Material zum ausfuellen von periodontalen knochendefekten.
SE8303531D0 (sv) Farmaceutisk komposition
DE69730314D1 (de) Dosierungsform von ibuprofen
ES8602890A1 (es) Un procedimiento para fabricar una composicion de pasta de madera esponjosa
IL62424A (en) Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them
ES474047A1 (es) Procedimiento para preparar un cebo para moscas sinantropas
IT1138143B (it) Composizione termoplastica da ciampaggio avente migliorata hebistenza allo svergolamento e procedimento per preparare la medesima
BR9810461B1 (pt) mÉtodo de preparar uma composiÇço de adesivo de dentadura e composiÇço da mesma.
ATE154011T1 (de) Inhibitoren der calciumaufnahme
FI830075A7 (fi) Polymeerikoostumuksia ja niiden käyttö liima-aineina tai liima- aineissa ja muissa koostumuksissa.
SE8204469L (sv) Malet risskal i kroppspuder
NO891675L (no) Kompositt-materialer for bruk i ortopedi.
KR890700335A (ko) 신규의 치아 조성물 및 그 제조방법
ATE45286T1 (de) Gammainterferon und lymphotoxin enthaltende synergistische zusammensetzung und ihre herstellung.
DE59205662D1 (de) Alginat-Abformmasse
ATE5356T1 (de) Impraegniermittel und seine verwendung.
EP0286601A3 (de) Pulveriges Deodorantmittel für Schuhe, besonders für Sportschuhe
MX159526A (es) Una composicion de porcelana pastosa almacenable para preparar protesis dentales
DE2961728D1 (en) Novel 2,6-dinitrobenzenamines, their preparation, composition containing them and their use as fungicides
ATE127455T1 (de) Inhibitoren der calciumaufnahme.
ES8404825A1 (es) Un procedimiento de fabricacion de una composicion en polvo, estable y dispersable en agua, de varias materias activas fitosanitarias.
DE3379733D1 (en) Fabric softening composition
ES8500928A1 (es) Procedimiento para la obtencion de oxaspirododecan-derivados de efecto perfumante

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time